Application | Comment | Organism |
---|---|---|
drug development | the enzyme is a target for design of active site inhibitors based on the structure of tick carboxypeptidase inhibitor, a potential antithrombolytic drug | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
recombinant expression of the zymogen in Pichia pastoris straim KM71 | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
recombinant enzyme in complex with tick carboxypeptidase inhibitor, sitting drop vapour diffusion method, mixing of equal volumes of protein and reservoir solutions, the latter containing 0.1 M bis-Tris. pH 5.5, 0.2 M lithium sulfate monohydrate, and 25% w/v PEG 3350, a few weeks at 20°C, X-ray diffraction structure determination and analysis at 2.0 A resolution | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
tick carboxypeptidase inhibitor | TCI, from Rhipicephalus bursa, recombinantly expressd in Escherichia coli strain BL21(DE3) periplasm and purification by cation exchange and adsorption chromatography, binding structure at the active site, overview | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P15086 | - |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
proteolytic modification | cleavage and activation of the recombinant zymogen by trypsin | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
pancreas | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
B carboxypeptidase | - |
Homo sapiens |
CPB | - |
Homo sapiens |